Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1996
05/02/1996WO1996012486A1 Use of [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo [2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease
05/02/1996WO1996012485A1 Treatment of disorders with duloxetine
05/02/1996WO1996012484A1 Antianemic agent containing iron and difructose
05/02/1996WO1996012483A1 Method of inhibiting nitric oxide formation
05/02/1996WO1996012482A1 Hydroxyethyl aminimides
05/02/1996WO1996012481A1 Autism remedy
05/02/1996WO1996012480A1 Polyamine compounds for treating vascular proliferative disorders
05/02/1996WO1996012479A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996WO1996012478A1 A controlled release nifedipine delivery device
05/02/1996WO1996012477A1 Controlled release oral delivery system containing oxybutynin
05/02/1996WO1996012476A1 Wet granulation formulation for a piperazinylcamphorsulfonyl oxytocin receptor antagonist
05/02/1996WO1996012475A1 Active agent transport systems
05/02/1996WO1996012474A1 Compositions for the delivery of antigens
05/02/1996WO1996012473A1 Compounds and compositions for delivering active agents
05/02/1996WO1996012472A1 Liposome composition containing selegilin
05/02/1996WO1996012471A1 Novel and improved aminoglycoside formulation for aerosolization
05/02/1996WO1996012470A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant
05/02/1996WO1996012442A1 Non-ozone depleting vapocoolants
05/02/1996WO1996012415A1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed
05/02/1996WO1996012407A1 Method for reducing bacterial contamination in an aquaculture
05/02/1996WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996WO1996006103A3 α-D-PENTOFURANOSIDE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND THEIR USE
05/02/1996WO1996004886A3 Gelling compositions comprising optically enriched gellants
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996WO1995034571A3 Drug salts
05/02/1996DE4439492A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
05/02/1996CA2203914A1 Method of inhibiting conditions associated with bradykinin
05/02/1996CA2203674A1 L-pyranosyl nucleosides
05/02/1996CA2203670A1 Use of ¬r-(z)|-alpha-(methoxyimino)-alpha-(1-azabicyclo ¬2.2.2| oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease
05/02/1996CA2203656A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
05/02/1996CA2203541A1 Competitive progesterone antagonists for demand-oriented female birth control
05/02/1996CA2203426A1 Heterocyclic compounds and their use
05/02/1996CA2203273A1 Microbial synthesis of hiv protease inhibitors
05/02/1996CA2203272A1 Microbial synthesis of hiv protease inhibitors
05/02/1996CA2203271A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996CA2203265A1 Production and use of human and plant methyltransferases
05/02/1996CA2203262A1 Nucleoside derivatives and process for preparing thereof
05/02/1996CA2203123A1 Hydroxyethyl aminimides
05/02/1996CA2203118A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant
05/02/1996CA2203106A1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed
05/02/1996CA2202891A1 Composition use of nucleoside analogues and gene transfection for tissue imaging and thereapy
05/02/1996CA2202774A1 Dermatological compositions and method of treatment of skin lesions therewith
05/02/1996CA2202299A1 Compositions for the delivery of antigens
05/02/1996CA2201728A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
05/02/1996CA2201113A1 Quinoline derivatives
05/02/1996CA2200990A1 Methods of inhibiting conditions associated with neuropeptide y
05/02/1996CA2200885A1 7-substituted 4-aza cholanic acid derivatives and their use
05/02/1996CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996CA2199980A1 Combination method for acne treatment
05/02/1996CA2199979A1 Combination method for acne treatment
05/02/1996CA2198914A1 Polyamine compounds for treating vascular proliferative disorders
05/02/1996CA2161603A1 Polymeric antitumor agents
05/01/1996EP0709394A2 Steroids with a 17-spiromethylene lactone or lactol group
05/01/1996EP0709386A1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/01/1996EP0709384A1 Benzylpiperidine derivatives having high affinity for binding sites of aminoacid receptors
05/01/1996EP0709383A1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
05/01/1996EP0709382A1 Aromatic dibenzofurane derivatives, pharmaceutical and cosmetic compositions containing them
05/01/1996EP0709381A1 Heterocyclic compounds and their preparation and use
05/01/1996EP0709378A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds
05/01/1996EP0709376A2 Therapeutic compounds
05/01/1996EP0709375A2 Therapeutic heterocycles
05/01/1996EP0709371A1 O-arylmethyl N-(thio)acyl hydroxylamines as ligands for the melatonine receptors, their processes of preparation and the pharmaceutical compositions containing them
05/01/1996EP0709304A1 Package for a veterinary implant
05/01/1996EP0709098A1 Compositions containing piperine
05/01/1996EP0709095A2 Method for treating anxiety using a tetrahydropyridine or azabicyclic oxadiazole or thiadiazole compound
05/01/1996EP0709094A2 Method for treating anxiety using a tetrahydropyridine oxadiazole or thiadiazole compound
05/01/1996EP0709093A2 Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound
05/01/1996EP0709092A2 Combinations of active ingredients for use against superinfections, containing wool wax acids and other fatty acids
05/01/1996EP0709091A2 Dermatologic compositions containing fatty acids and fatty acid glycerides against superinfections
05/01/1996EP0709090A2 Compositions for treating resistant tumors
05/01/1996EP0709089A2 Dermatologic compositions against superinfections containing ethoxylated and/or propoxylated alcohols and/or carboxylic acids
05/01/1996EP0709088A1 Transdermal therapeutic system for application of naloxone
05/01/1996EP0709082A2 Combinations of active ingredients based on wool wax acids and glycerides of saturated fatty acids efficient against impure skin, slight forms of acne as well as propionibacterium acnes
05/01/1996EP0709081A1 Composition containing a precursor of dihydroacetone
05/01/1996EP0708829A1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
05/01/1996EP0708785A1 Heparin derivatives having antimetastatic activity
05/01/1996EP0708779A1 Use of cephem derivatives as anti-metastatic agents
05/01/1996EP0708778A1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists
05/01/1996EP0708777A1 Abeo-ergoline derivatives as 5ht1a ligands
05/01/1996EP0708776A1 Antiallergic imidazoazepines
05/01/1996EP0708774A1 Imidazo [1,2-a]pyrazine-4-one, preparation thereof and drugs containing same
05/01/1996EP0708773A1 Fused cycloalkylimidazopyridines
05/01/1996EP0708772A1 IMIDAZO [4,5-c]PYRIDIN-4-AMINES
05/01/1996EP0708771A1 Benzyloxyquinuclidines as substance p antagonists
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708766A1 Use of coumarins as pla 2-inhibitors, new coumarins, process for preparing the same and medicaments
05/01/1996EP0708765A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists
05/01/1996EP0708764A1 Enanthioselective preparation of thiazole derivatives
05/01/1996EP0708763A1 Process for making hiv protease inhibitors
05/01/1996EP0708760A1 Cyclic hydrazine compounds
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0708751A1 Synthesis of combinatorial arrays of organic compounds through the use of multiple component combinatorial array syntheses
05/01/1996EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors
05/01/1996EP0708651A1 Therapeutic agent
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996EP0708647A1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor
05/01/1996EP0708646A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions
05/01/1996EP0708645A1 Use of compounds which inhibit phosphatidic acid formation for the manufacture of a medicament for the treatment of cancer
05/01/1996EP0708644A1 TREATMENT OF $i(CRYPTOCOCCUS NEOFORMANS) INFECTION
05/01/1996EP0708643A1 Transdermal melatonin delivery system
1 ... 6921 6922 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 6935 6936 6937 6938 6939 6940 6941 ... 7860